VPS35 and Parkinson disease: A Vps35 mutation (D620N) from late onset PD patients was recently reported (73), and a D620N-Vps35 mouse model exhibited reduced DAT surface expression and decreased DA clearance in ex vivo slices (74), consistent with disrupted and retromer-dependent DAT membrane delivery.